【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 330次   下载 374 本文二维码信息
码上扫一扫!
脓毒症休克快速心律失常研究进展
唐念中*,刘芬
0
(海军军医大学(第二军医大学)第一附属医院重症医学科, 上海 200081
*通信作者)
摘要:
快速心律失常是脓毒症休克的重要临床特点,控制不良的持续性心动过速与不良预后密切相关。脓毒症休克相关快速心律失常的发生机制复杂,药物治疗仍然是当今控制脓毒症休克相关心律失常的主要手段。药物选择存在多样性,对抗心律失常药物的选择及使用方法还有待进一步研究。本文主要对脓毒症休克相关快速心律失常的发病机制及治疗等方面的研究进展进行综述。
关键词:  脓毒症  脓毒症休克  快速心律失常  发病机制  药物疗法
DOI:10.16781/j.CN31-2187/R.20220642
投稿时间:2022-08-01修订日期:2023-02-28
基金项目:
Tachyarrhythmia in septic shock: research progress
TANG Nianzhong*,LIU Fen
(Department of Critical Care Medicine, The First Affiliated Hospital of Naval Medical University(Second Military Medical University), Shanghai 200081, China
*Corresponding author)
Abstract:
Tachyarrhythmia is an important clinical feature of septic shock. Poorly controlled persistent tachycardia is closely related to poor prognosis. The pathogenesis of septic shock-related tachyarrhythmia is complex, and drug therapy is still the main choice to control septic shock-related arrhythmia. Diversity of drug choices exists, so the selection and use of antiarrhythmic drugs need to be further studied. This article mainly reviews the research progress in the pathogenesis and treatment of septic shock-related tachyarrhythmia.
Key words:  sepsis  septic shock  tachyarrhythmia  pathogenesis  drug therapy